Research achievements
Over the years our funding has helped to build the capability and infrastructure of specialist cancer research teams in Sheffield. It's enabled them to produce research which has influenced cancer treatment both nationally and globally.
We're proud to enable research
Over the years, our funds have played a pivotal role in bringing world-class treatments and research to Weston Park Cancer Centre, giving our patients access to the latest advances in the treatment of the disease. Not only does this improve the quality of cancer services across the board but helps our world-leading clinicians better understand the disease, paving the way for the hope of one day finding a cure.
Did you know?
- Thanks to generous donations, the Cancer Clinical Trials Centre at Weston Park Cancer Centre in Sheffield opened in 1999. With the continued support of donors, the centre has now funded over 900 trials involving 16,000 patients and today is recognised as a pioneer of numerous advances.
- With the help of supporters, we funded the opening of a Clinical Research Unit in 2014. The unit enables Weston Park to expand its delivery of breakthrough treatments unavailable on the NHS.
- Our work often has a global impact. For example, Professor Rob Coleman, now one of our trustees, lead an international study which found that the bone-targeted drug Zoledronic acid increases the 10-year survival rates for post-menopausal breast cancer patients by 15%. As a result of this pioneering research, NICE now recommends this drug in their guidelines for treatment of post-menopausal breast cancer.
We've funded life-saving research and clinical trials
“There are a lot of people that can thank Weston Park for many, many years of life – normal life. I’m extremely proud of everything we’ve achieved, taking on new developments and treatments and I’ve been proud of the enhancements that Weston Park Cancer Charity has enabled.” Professor Barry Hancock
It makes all the difference to people like John who agreed to participate in a pioneering new drug trial after hearing the devastating news that his cancer was terminal.